Developing a promising therapeutic technology which may contribute to treat various amyloidosis related diseases, incl. Alzheimer’s Disease.
Venture Valuation (VV) interviewed TORII Shin-ichi, Ph.D., founder and CEO.
Would you like to be notified about new interviews, reports and other valuable content published by Venture Valuation?